Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2017 Feb 24;12(3):420–432. doi: 10.1007/s11481-017-9730-0

Figure 5. SIRT1 is a target of miR-34a and miR-138.

Figure 5

(A) Western blot analyses of SIRT1 and GFAP in lysates of A172 transfected with either miR-34a/miR-138 mimics or inhibitor. (B) Relative luciferase activity of WT/3′UTR mutant constructs of SIRT1 co-transfected with either the mimic of inhibitor of miR-34a/miR-138 in A172 cells.